A place for ipratropium bromide in the treatment of severe acute asthma
- PMID: 2932137
- DOI: 10.1016/0007-0971(85)90071-3
A place for ipratropium bromide in the treatment of severe acute asthma
Abstract
Twenty-four consecutive patients admitted to hospital with severe acute asthma were studied. Eleven were given 10 mg salbutamol by nebulizer followed 2 hours later by 500 micrograms of nebulized ipratropium bromide. These patients had a greater response in PEFR than 13 patients given two doses of 10 mg salbutamol 2 hours apart.